Wordt geladen...
Resistance to therapy in estrogen receptor positive and human epidermal growth factor 2 positive breast cancers: progress with latest therapeutic strategies
In this article, we focus on the subtype of estrogen receptor (ER)-positive, human epidermal growth factor 2 (HER2)-positive breast cancer (BC). Preclinical and clinical data indicate a complex molecular bidirectional crosstalk between the ER and HER2 pathways. This crosstalk probably constitutes on...
Bewaard in:
| Gepubliceerd in: | Ther Adv Med Oncol |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
SAGE Publications
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5066545/ https://ncbi.nlm.nih.gov/pubmed/27800032 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834016665077 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|